Biofrontera Inc (BFRI) Q3 2024 Earnings Call Highlights: Strategic Advancements Amidst Revenue ... [Yahoo! Finance]
Biofrontera Inc. (BFRI)
Company Research
Source: Yahoo! Finance
Biofrontera Inc ( NASDAQ:BFRI ) reported a significant increase in the total number of Ameluz tubes ordered, alongside a reduction in costs. The company improved its FDA label, allowing the use of up to three tubes of Ameluz per treatment, enhancing flexibility for healthcare providers. Outstanding clinical results were achieved for a new indication, with a high degree of statistical significance in the superficial BCC phase three study. The launch of the RDO LED XL lamp has been successful, with 105 new lamps installed in the first three quarters of 2024. Biofrontera Inc ( NASDAQ:BFRI ) has taken control over clinical trials, leading to a reduced transfer price for Ameluz, which is expected to improve profitability. Revenues in the third quarter were impacted by delayed shipments due to Hurricane Milton, affecting growth figures. The net loss for the third quarter of 2024 was $5.7 million, although this was an improvement from the previous year. Adjusted EBITDA for the
Show less
Read more
Impact Snapshot
Event Time:
BFRI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BFRI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BFRI alerts
High impacting Biofrontera Inc. news events
Weekly update
A roundup of the hottest topics
BFRI
News
- Biofrontera Inc. (NASDAQ: BFRI) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $7.00 price target on the stock.MarketBeat
- Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business UpdateGlobeNewswire
- Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024 [Yahoo! Finance]Yahoo! Finance
- Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024Accesswire
BFRI
Earnings
- 11/13/24 - Miss
BFRI
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/14/24 - Form 10-Q
- BFRI's page on the SEC website